SL
Insider
Suvretta Capital Management, Llc
DirectorSuvretta Capital Management, Llc (Director) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (4 purchases, 0 sales, 2 filed past the two-business-day deadline), most often in BNTC. Across 4 priced purchase filings, the average 21-session return was +15.0% from execution and +9.0% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of BNTC (1,481,481 sh across 2 lots, as filed), executed Nov 7 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+15.0%
avg across 4 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+9.0%
same 4 filings, from disclosure
Filings, ttm
4
4 buys · 0 sells · 2 late
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$32.5M
shares × price, as filed
Last traded
Feb 6
Filed Feb 9
Median ADV $79.0M across their filed names
Impact on $10,000 · 12M
$13,842 (+38.4%)
S&P 500 $11,787 (+17.9%) · 20.6 pts ahead
Suvretta Capital Management, Llc
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $32.9M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
3 filings
Sector per market data · by filing · past 12 months
Most traded names
BNTC
BNTC
BNTC · 5 buys · 0 sells
5 filings
MANERecent filings
MANEPURCHASE
Veradermics, Incorporated
View filing →
$10.3M276,600 sh across 16 lots
Exec Feb 4
Filed Feb 9 · 6:28 PM ET † BNTCPURCHASE Benitec Biopharma Inc. View filing → $1.8M
134,307 sh across 4 lots
Exec Dec 23 2025
Filed Dec 29 2025 · 7:31 PM ET † BNTCPURCHASE Benitec Biopharma Inc. View filing → $361K
30,600 sh across 2 lots
Exec Dec 19 2025
Filed Dec 22 2025 · 7:45 PM ET BNTCPURCHASE Benitec Biopharma Inc. View filing → $20.0M
1,481,481 sh across 2 lots
Exec Nov 7 2025
Filed Nov 10 2025 · 9:51 PM ET BNTCPURCHASE Benitec Biopharma Inc. View filing → $120K
9,503 sh × $12.63
Exec Mar 31 2025
Filed Apr 2 2025 · 5:30 PM ET BNTCPURCHASE Benitec Biopharma Inc. View filing → $357K
37,190 sh × $9.60
Exec Dec 3 2024
Filed Dec 5 2024 · 5:30 PM ET